Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust NASDAQ Smart Grid ETF (GRID) vs Moderna, Inc. (MRNA) Price & Performance

First Trust NASDAQ Smart Grid ETFTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

First Trust NASDAQ Smart Grid ETF vs Moderna, Inc. — how do they compare? First Trust NASDAQ Smart Grid ETF trades at $179.6 (market cap $12.13B), while Moderna, Inc. trades at $195.76 (market cap $78.65B). The key difference: Moderna, Inc. is far larger — about 6.5× First Trust NASDAQ Smart Grid ETF's market cap, and Moderna, Inc. is trading nearer its 52-week high, First Trust NASDAQ Smart Grid ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ Smart Grid ETF for 10 Days and Moderna, Inc. for 59 Days on average.

GRIDMRNA
Market Cap
$12.13B$78.65B
Volume
624,37837,373,437
Sector
Sector/ThematicHealth
52-Week High
$199.80$203.46
52-Week Low
$146.51$22.36
Typical Hold Time
10 Days59 Days
Enterprise Value
—$74.80B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust NASDAQ Smart Grid ETF

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $196.48, up 4.81% amid Nasdaq-100 inclusion news, though it remains well below the analyst consensus target of $115.70. The stock shows bullish technical momentum with recent earnings beats, but faces fundamental challenges with negative profit margins and declining revenue from pandemic-era highs. The company's cash flow improved in 2025, turning positive for the first time since 2022, while its pipeline, including oncology vaccines, attracts investor interest despite valuation concerns.

Outlook: Near-term momentum from index fund buying and pipeline updates may support the stock, but high valuation multiples and persistent losses pose significant risks. Long-term growth depends on successful commercialization of non-COVID products, with current prices reflecting optimistic scenarios. Investors should weigh the potential of the mRNA platform against execution risks and competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GRID
67% Buy33% Sell
Avg holding period · 10 Days
MRNA
29% Buy71% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About First Trust NASDAQ Smart Grid ETF

First Trust NASDAQ Smart Grid Infrastructure ETF seeks to track companies involved in smart grid and electricity infrastructure. Its holdings include businesses related to power networks, energy management, and grid technologies.

Read more on GRID →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →